LRP5 and prostate carcinoma: A 2019 review summarized studies on low-density lipoprotein in metabolism, noting that during the study period, LRP5 was proven to play a role in osteosarcoma and in non-cancer conditions such as the chondrocytic subtype of prostate cancer and osteoporosis (32).